![Mohammed Afshar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mohammed Afshar is the founder.
Dr. Afshar was the founder of Ariana Pharmaceuticals SA, serving as Chief Executive Officer & Director since 2003.
Dr. Afshar is also the founder of RiboTargets Ltd. Former job at The University of York as Research Fellow.
Former job at Génomic Vision SA as Member-Supervisory Board.
Education at Université de Montpellier with undergraduate, graduate, and doctorate degrees.
| Sociétés | Poste | Fin |
|---|---|---|
Ariana Pharmaceuticals SA
 Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Fondateur | 08/08/2024 |
| GENOMIC VISION | Directeur/Membre du Conseil | - |
The University of York
 The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Directeur Technique/Scientifique/R&D | - |
RiboTargets Ltd.
 RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 5 |
|---|---|
RiboTargets Ltd.
RiboTargets Ltd. Pharmaceuticals: OtherHealth Technology Pharmaceutical research company | Health Technology |
Université de Montpellier
 Université de Montpellier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of York
The University of York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ariana Pharmaceuticals SA
Ariana Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Provides pharmaceutical, clinical and data technology | Health Technology |
Génomic Vision SA
 Génomic Vision SA Medical SpecialtiesHealth Technology Develops diagnostic tools using deoxyribonucleic acid analysis | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
